en dash
Okumaya devam et...
← Previous revision | Revision as of 12:36, 2 May 2024 |
| Line 4: | Line 4: |
| Lötvall's laboratory proposed [[extracellular vesicle]]s such as [[Exosome complex|exosome]]s and [[microvesicle]]s as shuttles of [[RNA]] molecules between cells<ref>{{cite journal |vauthors=Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO |title=Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells |journal=[[Nature Cell Biology]] |volume=9 |issue=6 |pages=654–9 |date=June 2007 |pmid=17486113 |doi=10.1038/ncb1596 |s2cid=8599814 }}<!--|accessdate=2011-01-03--></ref> along with several other groups in 2006,<ref>{{cite journal | pmid=16283305 | date=2006 | last1=Baj-Krzyworzeka | first1=M. | last2=Szatanek | first2=R. | last3=Weglarczyk | first3=K. | last4=Baran | first4=J. | last5=Urbanowicz | first5=B. | last6=Brański | first6=P. | last7=Ratajczak | first7=M. Z. | last8=Zembala | first8=M. | title=Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes | journal=Cancer Immunology, Immunotherapy | volume=55 | issue=7 | pages=808–818 | doi=10.1007/s00262-005-0075-9 | s2cid=25723677 }}</ref> 2007,<ref>{{cite journal | pmid=17556595 | date=2007 | last1=Aliotta | first1=J. M. | last2=Sanchez-Guijo | first2=F. M. | last3=Dooner | first3=G. J. | last4=Johnson | first4=K. W. | last5=Dooner | first5=M. S. | last6=Greer | first6=K. A. | last7=Greer | first7=D. | last8=Pimentel | first8=J. | last9=Kolankiewicz | first9=L. M. | last10=Puente | first10=N. | last11=Faradyan | first11=S. | last12=Ferland | first12=P. | last13=Bearer | first13=E. L. | last14=Passero | first14=M. A. | last15=Adedi | first15=M. | last16=Colvin | first16=G. A. | last17=Quesenberry | first17=P. J. | title=Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: A novel mechanism for phenotype modulation | journal=Stem Cells | volume=25 | issue=9 | pages=2245–2256 | doi=10.1634/stemcells.2007-0128 | pmc=3376082 }}</ref> and 2008.<ref>{{cite journal |vauthors=Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky "*****", Breakefield XO |title=Glioblastoma microvesicles |journal=[[Nature Cell Biology]] |volume=10 |issue=12 |pages=1470–6 |date=Dec 2008 |pmid=19011622 |doi=10.1038/ncb1800 |pmc=3423894 }}</ref> | Lötvall's laboratory proposed [[extracellular vesicle]]s such as [[Exosome complex|exosome]]s and [[microvesicle]]s as shuttles of [[RNA]] molecules between cells<ref>{{cite journal |vauthors=Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO |title=Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells |journal=[[Nature Cell Biology]] |volume=9 |issue=6 |pages=654–9 |date=June 2007 |pmid=17486113 |doi=10.1038/ncb1596 |s2cid=8599814 }}<!--|accessdate=2011-01-03--></ref> along with several other groups in 2006,<ref>{{cite journal | pmid=16283305 | date=2006 | last1=Baj-Krzyworzeka | first1=M. | last2=Szatanek | first2=R. | last3=Weglarczyk | first3=K. | last4=Baran | first4=J. | last5=Urbanowicz | first5=B. | last6=Brański | first6=P. | last7=Ratajczak | first7=M. Z. | last8=Zembala | first8=M. | title=Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes | journal=Cancer Immunology, Immunotherapy | volume=55 | issue=7 | pages=808–818 | doi=10.1007/s00262-005-0075-9 | s2cid=25723677 }}</ref> 2007,<ref>{{cite journal | pmid=17556595 | date=2007 | last1=Aliotta | first1=J. M. | last2=Sanchez-Guijo | first2=F. M. | last3=Dooner | first3=G. J. | last4=Johnson | first4=K. W. | last5=Dooner | first5=M. S. | last6=Greer | first6=K. A. | last7=Greer | first7=D. | last8=Pimentel | first8=J. | last9=Kolankiewicz | first9=L. M. | last10=Puente | first10=N. | last11=Faradyan | first11=S. | last12=Ferland | first12=P. | last13=Bearer | first13=E. L. | last14=Passero | first14=M. A. | last15=Adedi | first15=M. | last16=Colvin | first16=G. A. | last17=Quesenberry | first17=P. J. | title=Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: A novel mechanism for phenotype modulation | journal=Stem Cells | volume=25 | issue=9 | pages=2245–2256 | doi=10.1634/stemcells.2007-0128 | pmc=3376082 }}</ref> and 2008.<ref>{{cite journal |vauthors=Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky "*****", Breakefield XO |title=Glioblastoma microvesicles |journal=[[Nature Cell Biology]] |volume=10 |issue=12 |pages=1470–6 |date=Dec 2008 |pmid=19011622 |doi=10.1038/ncb1800 |pmc=3423894 }}</ref> |
| Lötvall was a member of the Executive Committee of the [[European Academy of Allergy and Clinical Immunology]], its secretary general from 2005 to 2009, and its president from June 2009 to June 2011.<ref>{{cite web |url=http://www.eaaci.net/organization/committees/executive |title=Executive Committee |publisher=European Academy of Allergy and Clinical Immunology |access-date=2011-01-03}}</ref> Lötvall was also co-[[editor-in-chief]] of ''[[Respiratory Research]]'' from 2003 to 2018.<ref>{{cite journal |vauthors=Lotvall J, Panettieri Jr RA |date= 2018 |title=Thank you and farewell after 15 years editing Respiratory Research |journal=[[Respiratory Research]] |volume=19 |issue=232 |page= 232 |doi=10.1186/s12931-018-0929-2 |pmid= 30477500 |pmc=6258390 |doi-access= free }}</ref> He was the first president of the [[International Society for Extracellular Vesicles]] (2012-2016) and chaired the first society meeting in Gothenburg, in April 2012.<ref>{{cite web|url=http://www.isev.org/node/17 |title=Executive Board (2012-2014) | ISEV - International Society for Extracellular Vesicles |publisher=ISEV |access-date=2012-10-08 |url-status=dead |archive-url=https://web.archive.org/web/20130805015720/http://www.isev.org/node/17 |archive-date=2013-08-05 }}</ref> Lötvall became Editor-in-Chief of Journal of Extracellular Vesicles in 2019. | Lötvall was a member of the Executive Committee of the [[European Academy of Allergy and Clinical Immunology]], its secretary general from 2005 to 2009, and its president from June 2009 to June 2011.<ref>{{cite web |url=http://www.eaaci.net/organization/committees/executive |title=Executive Committee |publisher=European Academy of Allergy and Clinical Immunology |access-date=2011-01-03}}</ref> Lötvall was also co-[[editor-in-chief]] of ''[[Respiratory Research]]'' from 2003 to 2018.<ref>{{cite journal |vauthors=Lotvall J, Panettieri Jr RA |date= 2018 |title=Thank you and farewell after 15 years editing Respiratory Research |journal=[[Respiratory Research]] |volume=19 |issue=232 |page= 232 |doi=10.1186/s12931-018-0929-2 |pmid= 30477500 |pmc=6258390 |doi-access= free }}</ref> He was the first president of the [[International Society for Extracellular Vesicles]] (2012–2016) and chaired the first society meeting in Gothenburg, in April 2012.<ref>{{cite web|url=http://www.isev.org/node/17 |title=Executive Board (2012-2014) | ISEV - International Society for Extracellular Vesicles |publisher=ISEV |access-date=2012-10-08 |url-status=dead |archive-url=https://web.archive.org/web/20130805015720/http://www.isev.org/node/17 |archive-date=2013-08-05 }}</ref> Lötvall became Editor-in-Chief of Journal of Extracellular Vesicles in 2019. |
| Lötvall studied medicine at the [[Karolinska Institutet]] in Stockholm (1981–1985) and graduated from the Medical School of the University of Gothenburg in 1987. He became interested in asthma research in the mid-1980s. After studying as a visiting fellow at the [[Imperial College School of Medicine|National Heart and Lung Institute]], London from 1988 to 1990), Lötvall defended his thesis in February, 1991. He trained in both [[pharmacology]] and [[allergy|allergology]], and became a specialist in these areas in 1997 and 1999, respectively. He became associate professor (docent) at the University of Gothenburg in 1993 and full professor of clinical allergology in 2002. He is currently Chief Scientific Officer of ExoCoBio.<ref>{{cite web|url=https://www.exocobio.com/default/en..._board_id=11&&com_board_idx=43|title=ExoCoBio website}}</ref><ref>{{cite web|url=https://en.prnasia.com/releases/apa...-exosome-summit-371901.shtml|title=ExoCoBio's First Global Regenerative Aesthetic Exosome Summit|access-date=2024-01-15}}</ref> | Lötvall studied medicine at the [[Karolinska Institutet]] in Stockholm (1981–1985) and graduated from the Medical School of the University of Gothenburg in 1987. He became interested in asthma research in the mid-1980s. After studying as a visiting fellow at the [[Imperial College School of Medicine|National Heart and Lung Institute]], London from 1988 to 1990), Lötvall defended his thesis in February, 1991. He trained in both [[pharmacology]] and [[allergy|allergology]], and became a specialist in these areas in 1997 and 1999, respectively. He became associate professor (docent) at the University of Gothenburg in 1993 and full professor of clinical allergology in 2002. He is currently Chief Scientific Officer of ExoCoBio.<ref>{{cite web|url=https://www.exocobio.com/default/en..._board_id=11&&com_board_idx=43|title=ExoCoBio website}}</ref><ref>{{cite web|url=https://en.prnasia.com/releases/apa...-exosome-summit-371901.shtml|title=ExoCoBio's First Global Regenerative Aesthetic Exosome Summit|access-date=2024-01-15}}</ref> |
Okumaya devam et...